Global Nocturia Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Underlying Cause
1.3.1 Global Nocturia Market Size Growth Rate by Underlying Cause: 2020 VS 2024 VS 2031
1.3.2 For Nocturnal Polyuria
1.3.3 For Overactive Bladder
1.3.4 For Prostate-related Nocturia
1.3.5 Others
1.4 Market by Drug Category
1.4.1 Global Nocturia Market Size Growth Rate by Drug Category: 2020 VS 2024 VS 2031
1.4.2 Hormonal Drugs
1.4.3 Urological Functional Agents
1.4.4 BPH Symptom Therapies
1.4.5 Diuretics
1.4.6 Others
1.5 Market by Sale Channels
1.5.1 Global Nocturia Market Growth by Sale Channels: 2020 VS 2024 VS 2031
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2020-2031)
2.2 Global Nocturia Growth Trends by Region
2.2.1 Global Nocturia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nocturia Historic Market Size by Region (2020-2025)
2.2.3 Nocturia Forecasted Market Size by Region (2026-2031)
2.3 Nocturia Market Dynamics
2.3.1 Nocturia Industry Trends
2.3.2 Nocturia Market Drivers
2.3.3 Nocturia Market Challenges
2.3.4 Nocturia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Revenue
3.1.1 Global Top Nocturia Players by Revenue (2020-2025)
3.1.2 Global Nocturia Revenue Market Share by Players (2020-2025)
3.2 Global Top Nocturia Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nocturia Revenue
3.4 Global Nocturia Market Concentration Ratio
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2024
3.5 Global Key Players of Nocturia Head office and Area Served
3.6 Global Key Players of Nocturia, Product and Application
3.7 Global Key Players of Nocturia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturia Breakdown Data by Type
4.1 Global Nocturia Historic Market Size by Type (2020-2025)
4.2 Global Nocturia Forecasted Market Size by Type (2026-2031)
5 Nocturia Breakdown Data by Sale Channels
5.1 Global Nocturia Historic Market Size by Sale Channels (2020-2025)
5.2 Global Nocturia Forecasted Market Size by Sale Channels (2026-2031)
6 North America
6.1 North America Nocturia Market Size (2020-2031)
6.2 North America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nocturia Market Size by Country (2020-2025)
6.4 North America Nocturia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nocturia Market Size (2020-2031)
7.2 Europe Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nocturia Market Size by Country (2020-2025)
7.4 Europe Nocturia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nocturia Market Size (2020-2031)
8.2 Asia-Pacific Nocturia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nocturia Market Size by Region (2020-2025)
8.4 Asia-Pacific Nocturia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nocturia Market Size (2020-2031)
9.2 Latin America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nocturia Market Size by Country (2020-2025)
9.4 Latin America Nocturia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturia Market Size (2020-2031)
10.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nocturia Market Size by Country (2020-2025)
10.4 Middle East & Africa Nocturia Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2020-2025)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Details
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2020-2025)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2020-2025)
11.10.5 Mylan Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Nocturia Introduction
11.11.4 Novartis Revenue in Nocturia Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Nocturia Introduction
11.12.4 Johnson & Johnson Revenue in Nocturia Business (2020-2025)
11.12.5 Johnson & Johnson Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Nocturia Introduction
11.13.4 Merck Revenue in Nocturia Business (2020-2025)
11.13.5 Merck Recent Development
11.14 Astra Zeneca
11.14.1 Astra Zeneca Company Details
11.14.2 Astra Zeneca Business Overview
11.14.3 Astra Zeneca Nocturia Introduction
11.14.4 Astra Zeneca Revenue in Nocturia Business (2020-2025)
11.14.5 Astra Zeneca Recent Development
11.15 Bristol-Myers Squibb
11.15.1 Bristol-Myers Squibb Company Details
11.15.2 Bristol-Myers Squibb Business Overview
11.15.3 Bristol-Myers Squibb Nocturia Introduction
11.15.4 Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025)
11.15.5 Bristol-Myers Squibb Recent Development
11.16 Hainan Zhonghe Pharmaceutical
11.16.1 Hainan Zhonghe Pharmaceutical Company Details
11.16.2 Hainan Zhonghe Pharmaceutical Business Overview
11.16.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.16.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.16.5 Hainan Zhonghe Pharmaceutical Recent Development
11.17 Fosun Pharma
11.17.1 Fosun Pharma Company Details
11.17.2 Fosun Pharma Business Overview
11.17.3 Fosun Pharma Nocturia Introduction
11.17.4 Fosun Pharma Revenue in Nocturia Business (2020-2025)
11.17.5 Fosun Pharma Recent Development
11.18 Hybio Pharmaceutical
11.18.1 Hybio Pharmaceutical Company Details
11.18.2 Hybio Pharmaceutical Business Overview
11.18.3 Hybio Pharmaceutical Nocturia Introduction
11.18.4 Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.18.5 Hybio Pharmaceutical Recent Development
11.19 Rechon Life Science AB
11.19.1 Rechon Life Science AB Company Details
11.19.2 Rechon Life Science AB Business Overview
11.19.3 Rechon Life Science AB Nocturia Introduction
11.19.4 Rechon Life Science AB Revenue in Nocturia Business (2020-2025)
11.19.5 Rechon Life Science AB Recent Development
11.20 Zhejiang Conba Pharmaceutical
11.20.1 Zhejiang Conba Pharmaceutical Company Details
11.20.2 Zhejiang Conba Pharmaceutical Business Overview
11.20.3 Zhejiang Conba Pharmaceutical Nocturia Introduction
11.20.4 Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.20.5 Zhejiang Conba Pharmaceutical Recent Development
11.21 Chengdu Leer Pharmaceutical
11.21.1 Chengdu Leer Pharmaceutical Company Details
11.21.2 Chengdu Leer Pharmaceutical Business Overview
11.21.3 Chengdu Leer Pharmaceutical Nocturia Introduction
11.21.4 Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.21.5 Chengdu Leer Pharmaceutical Recent Development
11.22 Nanjing Xingyin Pharmaceutical Group
11.22.1 Nanjing Xingyin Pharmaceutical Group Company Details
11.22.2 Nanjing Xingyin Pharmaceutical Group Business Overview
11.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Introduction
11.22.4 Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025)
11.22.5 Nanjing Xingyin Pharmaceutical Group Recent Development
11.23 Sun Pharmaceutical Industries Ltd.
11.23.1 Sun Pharmaceutical Industries Ltd. Company Details
11.23.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Introduction
11.23.4 Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025)
11.23.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.24 APOTEX INC
11.24.1 APOTEX INC Company Details
11.24.2 APOTEX INC Business Overview
11.24.3 APOTEX INC Nocturia Introduction
11.24.4 APOTEX INC Revenue in Nocturia Business (2020-2025)
11.24.5 APOTEX INC Recent Development
11.25 Sagent Pharmaceuticals
11.25.1 Sagent Pharmaceuticals Company Details
11.25.2 Sagent Pharmaceuticals Business Overview
11.25.3 Sagent Pharmaceuticals Nocturia Introduction
11.25.4 Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025)
11.25.5 Sagent Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Desmopressin
Table 3. Key Players of Anticholinergic Drugs
Table 4. Key Players of Alpha Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nocturia Market Size Growth Rate by Underlying Cause (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of For Nocturnal Polyuria
Table 9. Key Players of For Overactive Bladder
Table 10. Key Players of For Prostate-related Nocturia
Table 11. Key Players of Others
Table 12. Global Nocturia Market Size Growth Rate by Drug Category (US$ Million): 2020 VS 2024 VS 2031
Table 13. Key Players of Hormonal Drugs
Table 14. Key Players of Urological Functional Agents
Table 15. Key Players of BPH Symptom Therapies
Table 16. Key Players of Diuretics
Table 17. Key Players of Others
Table 18. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Nocturia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 20. Global Nocturia Market Size by Region (2020-2025) & (US$ Million)
Table 21. Global Nocturia Market Share by Region (2020-2025)
Table 22. Global Nocturia Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 23. Global Nocturia Market Share by Region (2026-2031)
Table 24. Nocturia Market Trends
Table 25. Nocturia Market Drivers
Table 26. Nocturia Market Challenges
Table 27. Nocturia Market Restraints
Table 28. Global Nocturia Revenue by Players (2020-2025) & (US$ Million)
Table 29. Global Nocturia Market Share by Players (2020-2025)
Table 30. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2024)
Table 31. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2024
Table 32. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2020-2025)
Table 33. Global Key Players of Nocturia, Headquarters and Area Served
Table 34. Global Key Players of Nocturia, Product and Application
Table 35. Global Key Players of Nocturia, Date of Enter into This Industry
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Nocturia Market Size by Type (2020-2025) & (US$ Million)
Table 38. Global Nocturia Revenue Market Share by Type (2020-2025)
Table 39. Global Nocturia Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 40. Global Nocturia Revenue Market Share by Type (2026-2031)
Table 41. Global Nocturia Market Size by Sale Channels (2020-2025) & (US$ Million)
Table 42. Global Nocturia Revenue Market Share by Sale Channels (2020-2025)
Table 43. Global Nocturia Forecasted Market Size by Sale Channels (2026-2031) & (US$ Million)
Table 44. Global Nocturia Revenue Market Share by Sale Channels (2026-2031)
Table 45. North America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. North America Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 47. North America Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 48. Europe Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Europe Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 50. Europe Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 51. Asia-Pacific Nocturia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 52. Asia-Pacific Nocturia Market Size by Region (2020-2025) & (US$ Million)
Table 53. Asia-Pacific Nocturia Market Size by Region (2026-2031) & (US$ Million)
Table 54. Latin America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Latin America Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 56. Latin America Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 57. Middle East & Africa Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 58. Middle East & Africa Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 59. Middle East & Africa Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 60. Astellas Pharma Company Details
Table 61. Astellas Pharma Business Overview
Table 62. Astellas Pharma Nocturia Product
Table 63. Astellas Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 64. Astellas Pharma Recent Development
Table 65. Allergan Company Details
Table 66. Allergan Business Overview
Table 67. Allergan Nocturia Product
Table 68. Allergan Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. Ferring Pharmaceuticals Company Details
Table 71. Ferring Pharmaceuticals Business Overview
Table 72. Ferring Pharmaceuticals Nocturia Product
Table 73. Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 74. Ferring Pharmaceuticals Recent Development
Table 75. Eli Lilly Company Details
Table 76. Eli Lilly Business Overview
Table 77. Eli Lilly Nocturia Product
Table 78. Eli Lilly Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 79. Eli Lilly Recent Development
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Nocturia Product
Table 83. GlaxoSmithKline Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 84. GlaxoSmithKline Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Nocturia Product
Table 88. Sanofi Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Nocturia Product
Table 93. Pfizer Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Nocturia Product
Table 98. Abbott Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 99. Abbott Recent Development
Table 100. Teva Company Details
Table 101. Teva Business Overview
Table 102. Teva Nocturia Product
Table 103. Teva Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 104. Teva Recent Development
Table 105. Mylan Company Details
Table 106. Mylan Business Overview
Table 107. Mylan Nocturia Product
Table 108. Mylan Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Novartis Company Details
Table 111. Novartis Business Overview
Table 112. Novartis Nocturia Product
Table 113. Novartis Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 114. Novartis Recent Development
Table 115. Johnson & Johnson Company Details
Table 116. Johnson & Johnson Business Overview
Table 117. Johnson & Johnson Nocturia Product
Table 118. Johnson & Johnson Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 119. Johnson & Johnson Recent Development
Table 120. Merck Company Details
Table 121. Merck Business Overview
Table 122. Merck Nocturia Product
Table 123. Merck Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 124. Merck Recent Development
Table 125. Astra Zeneca Company Details
Table 126. Astra Zeneca Business Overview
Table 127. Astra Zeneca Nocturia Product
Table 128. Astra Zeneca Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 129. Astra Zeneca Recent Development
Table 130. Bristol-Myers Squibb Company Details
Table 131. Bristol-Myers Squibb Business Overview
Table 132. Bristol-Myers Squibb Nocturia Product
Table 133. Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 134. Bristol-Myers Squibb Recent Development
Table 135. Hainan Zhonghe Pharmaceutical Company Details
Table 136. Hainan Zhonghe Pharmaceutical Business Overview
Table 137. Hainan Zhonghe Pharmaceutical Nocturia Product
Table 138. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 139. Hainan Zhonghe Pharmaceutical Recent Development
Table 140. Fosun Pharma Company Details
Table 141. Fosun Pharma Business Overview
Table 142. Fosun Pharma Nocturia Product
Table 143. Fosun Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 144. Fosun Pharma Recent Development
Table 145. Hybio Pharmaceutical Company Details
Table 146. Hybio Pharmaceutical Business Overview
Table 147. Hybio Pharmaceutical Nocturia Product
Table 148. Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 149. Hybio Pharmaceutical Recent Development
Table 150. Rechon Life Science AB Company Details
Table 151. Rechon Life Science AB Business Overview
Table 152. Rechon Life Science AB Nocturia Product
Table 153. Rechon Life Science AB Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 154. Rechon Life Science AB Recent Development
Table 155. Zhejiang Conba Pharmaceutical Company Details
Table 156. Zhejiang Conba Pharmaceutical Business Overview
Table 157. Zhejiang Conba Pharmaceutical Nocturia Product
Table 158. Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 159. Zhejiang Conba Pharmaceutical Recent Development
Table 160. Chengdu Leer Pharmaceutical Company Details
Table 161. Chengdu Leer Pharmaceutical Business Overview
Table 162. Chengdu Leer Pharmaceutical Nocturia Product
Table 163. Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 164. Chengdu Leer Pharmaceutical Recent Development
Table 165. Nanjing Xingyin Pharmaceutical Group Company Details
Table 166. Nanjing Xingyin Pharmaceutical Group Business Overview
Table 167. Nanjing Xingyin Pharmaceutical Group Nocturia Product
Table 168. Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 169. Nanjing Xingyin Pharmaceutical Group Recent Development
Table 170. Sun Pharmaceutical Industries Ltd. Company Details
Table 171. Sun Pharmaceutical Industries Ltd. Business Overview
Table 172. Sun Pharmaceutical Industries Ltd. Nocturia Product
Table 173. Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 174. Sun Pharmaceutical Industries Ltd. Recent Development
Table 175. APOTEX INC Company Details
Table 176. APOTEX INC Business Overview
Table 177. APOTEX INC Nocturia Product
Table 178. APOTEX INC Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 179. APOTEX INC Recent Development
Table 180. Sagent Pharmaceuticals Company Details
Table 181. Sagent Pharmaceuticals Business Overview
Table 182. Sagent Pharmaceuticals Nocturia Product
Table 183. Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 184. Sagent Pharmaceuticals Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
Table 188. Authors List of This Report


List of Figures
Figure 1. Nocturia Picture
Figure 2. Global Nocturia Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nocturia Market Share by Type: 2024 VS 2031
Figure 4. Desmopressin Features
Figure 5. Anticholinergic Drugs Features
Figure 6. Alpha Blockers Features
Figure 7. Diuretics Features
Figure 8. Others Features
Figure 9. Global Nocturia Market Size Comparison by Underlying Cause (2020-2031) & (US$ Million)
Figure 10. For Nocturnal Polyuria Features
Figure 11. For Overactive Bladder Features
Figure 12. For Prostate-related Nocturia Features
Figure 13. Others Features
Figure 14. Global Nocturia Market Size Comparison by Drug Category (2020-2031) & (US$ Million)
Figure 15. Hormonal Drugs Features
Figure 16. Urological Functional Agents Features
Figure 17. BPH Symptom Therapies Features
Figure 18. Diuretics Features
Figure 19. Others Features
Figure 20. Global Nocturia Market Size by Sale Channels (2020-2031) & (US$ Million)
Figure 21. Global Nocturia Market Share by Sale Channels: 2024 VS 2031
Figure 22. Hospital Pharmacies Case Studies
Figure 23. Retail Pharmacies Case Studies
Figure 24. Online Pharmacies Case Studies
Figure 25. Nocturia Report Years Considered
Figure 26. Global Nocturia Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 27. Global Nocturia Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 28. Global Nocturia Market Share by Region: 2024 VS 2031
Figure 29. Global Nocturia Market Share by Players in 2024
Figure 30. Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 31. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2024
Figure 32. North America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. North America Nocturia Market Share by Country (2020-2031)
Figure 34. United States Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Canada Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Europe Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Europe Nocturia Market Share by Country (2020-2031)
Figure 38. Germany Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. France Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. U.K. Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Italy Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Russia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Ireland Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Nocturia Market Share by Region (2020-2031)
Figure 46. China Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Japan Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. South Korea Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. India Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Australia & New Zealand Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Latin America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Latin America Nocturia Market Share by Country (2020-2031)
Figure 54. Mexico Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Brazil Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Middle East & Africa Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Middle East & Africa Nocturia Market Share by Country (2020-2031)
Figure 58. Israel Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. UAE Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 61. Astellas Pharma Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 62. Allergan Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 63. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 64. Eli Lilly Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 66. Sanofi Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 67. Pfizer Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 68. Abbott Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 69. Teva Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 70. Mylan Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 71. Novartis Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 72. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 73. Merck Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 74. Astra Zeneca Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 75. Bristol-Myers Squibb Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 76. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 77. Fosun Pharma Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 78. Hybio Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 79. Rechon Life Science AB Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 80. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 81. Chengdu Leer Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 82. Nanjing Xingyin Pharmaceutical Group Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 83. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 84. APOTEX INC Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 85. Sagent Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit